HAVCR2 and acute myeloid leukemia: proposed the hypothesis that TIM-3 on AML stem cells interacts with Gal-9 on MDSCs, thereby promoting the expansion of MDSCs and their differentiation into tumor-associated macrophages (TAMs) (144).